An investigation in NASDAQ:AMAG shares was announced over possible breaches of fiduciary duties by certain directors at AMAG Pharmaceuticals.
Investors who purchased shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain AMAG Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.
AMAG Pharmaceuticals, Inc. reported that its annual Total Revenue rise from $124.38 million in 2014 to $418.28 million in 2015 while its Net Income declined from $135.82 million in 2014 to $32.78 million in 2015.Shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) declined from $75.77 per share in July 2015 to as low as $20.48 per share on February 12, 2016.
On March 10, 2016, NASDAQ:AMAG shares closed at $24.11 per share.
Those who purchased NASDAQ:AMAG shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com